Skip to main content
Article
Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.
All Scholarly Works
  • Edward Reiter, MD, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
9-1-2004
Abstract
Pubertal gynecomastia is thought to result from transient imbalances between estrogen and androgen concentrations. Anastrozole (ARIMIDEX), a potent and selective aromatase inhibitor, decreases estrogen and increases testosterone concentrations in pubertal
Publication ISSN
0022-4707
Citation Information
J Clin Endocrinol Metab 2004 Sep;89(9):4428-33.